{"status":"ok","message-type":"event-list","message":{"next-cursor":"98aeac49-75dc-4ae1-b059-c8aa794e7390","total-results":55,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-09-04T03:47:31Z","subj_id":"http:\/\/twitter.com\/cispt2\/statuses\/904551473442369536","id":"96a24787-b9de-4809-aeea-5374c327fd08","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170904-twitter-9696c670-fb94-404b-9cf2-9983ed99623d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/cispt2\/statuses\/904551473442369536","title":"Tweet 904551473442369536","issued":"2017-09-04T03:47:31.000Z","author":{"url":"http:\/\/www.twitter.com\/cispt2"},"original-tweet-url":"http:\/\/twitter.com\/cispt2\/statuses\/904551473442369536","original-tweet-author":null,"alternative-id":"904551473442369536"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1021\/jm0002127","url":"http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/jm0002127"},"timestamp":"2017-09-04T03:47:49Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-12-10T00:00:00Z","subj_id":"https:\/\/lens.org\/101-372-222-517-419","id":"2d80e0de-f7b2-f7fa-3767-0801950a9c33","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Amide Compound And Medicinal Use Thereof","pid":"https:\/\/lens.org\/101-372-222-517-419","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T00:42:26Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-01-19T00:00:00Z","subj_id":"https:\/\/lens.org\/116-330-710-807-609","id":"7f8c7e90-4535-5747-2f88-cf1d3cb2c5b5","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Preparation And Uses Of Obeticholic Acid","pid":"https:\/\/lens.org\/116-330-710-807-609","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T04:34:44Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2006-03-09T00:00:00Z","subj_id":"https:\/\/lens.org\/120-565-531-093-090","id":"9bf23ae6-135d-520d-6f02-86cbc0356835","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Modulators Of Nuclear Receptors","pid":"https:\/\/lens.org\/120-565-531-093-090","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:40:22Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-01-17T00:00:00Z","subj_id":"https:\/\/lens.org\/012-246-659-889-473","id":"e170ff8f-61fe-3c70-ddf3-1e5139fcae68","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Fxr (Nr1H4) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/012-246-659-889-473","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T06:08:53Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-08-16T00:00:00Z","subj_id":"https:\/\/lens.org\/124-647-521-513-762","id":"8c59c9ee-1fba-f719-5033-2a0a480b8c1c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Compounds And Methods For Modulating Fxr","pid":"https:\/\/lens.org\/124-647-521-513-762","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T06:42:37Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-10-25T00:00:00Z","subj_id":"https:\/\/lens.org\/127-164-062-492-618","id":"815e1dab-1f18-1328-c31f-4248bc5c0acf","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Process For Preparing Isoxazole Compounds","pid":"https:\/\/lens.org\/127-164-062-492-618","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T07:21:45Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2005-09-29T00:00:00Z","subj_id":"https:\/\/lens.org\/131-444-666-474-390","id":"b60ad111-5ca4-384a-ec10-85ed671bb9f9","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Treatment Of Fibrosis Using Fxr Ligands","pid":"https:\/\/lens.org\/131-444-666-474-390","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T08:27:23Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-04-18T00:00:00Z","subj_id":"https:\/\/lens.org\/132-277-924-964-60X","id":"c05f52e4-fd58-afb4-f387-81c2953454df","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Nr1H4 Nuclear Receptor Binding Compounds","pid":"https:\/\/lens.org\/132-277-924-964-60X","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T08:40:24Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-01-22T00:00:00Z","subj_id":"https:\/\/lens.org\/132-742-321-502-693","id":"3b5dd153-4797-291e-f0bc-393f8405e416","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Compounds And Methods For Modulating Fxr","pid":"https:\/\/lens.org\/132-742-321-502-693","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T08:47:46Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2006-04-25T00:00:00Z","subj_id":"https:\/\/lens.org\/136-327-779-295-232","id":"a984eba2-c5e9-fe59-fd2c-8f39a96c7541","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Nr1H4 Nuclear Receptor Binding Compounds","pid":"https:\/\/lens.org\/136-327-779-295-232","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T09:43:50Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-06-28T00:00:00Z","subj_id":"https:\/\/lens.org\/136-946-351-550-645","id":"5c05d3ca-2f09-78d8-0135-a158e723a3ec","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Compositions And Methods For Modulating Farnesoid X Receptors","pid":"https:\/\/lens.org\/136-946-351-550-645","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T09:53:32Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2003-02-27T00:00:00Z","subj_id":"https:\/\/lens.org\/144-102-584-864-485","id":"48496beb-042b-9fe9-74d7-253b7d04e6c5","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Nr1H4 Nuclear Receptor Binding Compounds","pid":"https:\/\/lens.org\/144-102-584-864-485","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T11:44:25Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2004-06-09T00:00:00Z","subj_id":"https:\/\/lens.org\/144-883-806-758-448","id":"56ef9dd0-ff36-ac69-ba27-86ced47d76e4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Assays For Ligands For Nuclear Receptors","pid":"https:\/\/lens.org\/144-883-806-758-448","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T11:56:49Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2006-06-22T00:00:00Z","subj_id":"https:\/\/lens.org\/151-588-184-693-820","id":"c5944d72-b5dc-fea5-5f0c-1bed27401cc9","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Diagnostics And Therapeutics For Diseases Associated With Nuclear Receptor Subfamily 1, Group H, Member 4 (Nr1H4)","pid":"https:\/\/lens.org\/151-588-184-693-820","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T13:40:49Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-01-19T00:00:00Z","subj_id":"https:\/\/lens.org\/152-680-950-438-385","id":"e72c2548-903f-211e-d081-e885a8b96b2f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Neurogenesis Via Modulation Of The Muscarinic Receptors","pid":"https:\/\/lens.org\/152-680-950-438-385","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T13:57:17Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-12-25T00:00:00Z","subj_id":"https:\/\/lens.org\/153-360-405-342-12X","id":"19fe345c-8d9b-2325-7ace-d12c4e7d4487","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Method Of Synthesizing Alkylated Bile Acid Derivatives","pid":"https:\/\/lens.org\/153-360-405-342-12X","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T14:07:58Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-06-22T00:00:00Z","subj_id":"https:\/\/lens.org\/154-795-140-937-660","id":"0965fb70-bf06-5d35-c16f-8774c00dbb1d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Fxr (Nr1H4) Modulating Compounds","pid":"https:\/\/lens.org\/154-795-140-937-660","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T14:29:47Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-07-28T00:00:00Z","subj_id":"https:\/\/lens.org\/154-923-483-251-234","id":"057220c9-bc75-82d9-3706-bea6b6ec0a79","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Modulation Of Neurogenesis By Ppar Agents","pid":"https:\/\/lens.org\/154-923-483-251-234","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T14:31:52Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2017-01-10T00:00:00Z","subj_id":"https:\/\/lens.org\/166-531-189-120-519","id":"b9451a40-9976-90f9-8c90-1b3434f2fbb6","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Fxr (Nr1H4) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/166-531-189-120-519","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T17:39:47Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-06-28T00:00:00Z","subj_id":"https:\/\/lens.org\/167-173-523-940-993","id":"d5187295-94d9-213d-6cd2-a6b3a58e9c24","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Compositions And Methods For Modulating Farnesoid X Receptors","pid":"https:\/\/lens.org\/167-173-523-940-993","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T17:50:08Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-04-18T00:00:00Z","subj_id":"https:\/\/lens.org\/169-989-204-582-054","id":"43fa9078-5156-6b28-db50-77c91f744487","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Fxr Nr1H4 Nuclear Receptor Binding Compounds","pid":"https:\/\/lens.org\/169-989-204-582-054","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T18:38:27Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2006-01-10T00:00:00Z","subj_id":"https:\/\/lens.org\/173-094-461-550-851","id":"ee8283be-7723-3280-3c8b-824ae0f52bb6","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Use Of Fxr Ligands","pid":"https:\/\/lens.org\/173-094-461-550-851","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T19:31:08Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-04-02T00:00:00Z","subj_id":"https:\/\/lens.org\/175-103-253-628-436","id":"59b77d87-c644-beca-5afc-16ccca56e457","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Treatment Of Fibrosis Using Fxr Ligands","pid":"https:\/\/lens.org\/175-103-253-628-436","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T20:06:21Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-12-02T00:00:00Z","subj_id":"https:\/\/lens.org\/175-129-175-736-68X","id":"70529a08-4d55-0876-8d49-acd4c35573ed","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Heterocyclic Cyclopropyl-Substituted Fxr Binding Compounds","pid":"https:\/\/lens.org\/175-129-175-736-68X","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T20:06:47Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-11-22T00:00:00Z","subj_id":"https:\/\/lens.org\/177-515-383-988-361","id":"8683474f-9dba-03ec-96d6-a9702da3f10f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Treatment Of Fibrosis Using Fxr Ligands","pid":"https:\/\/lens.org\/177-515-383-988-361","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T20:46:50Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-02-24T00:00:00Z","subj_id":"https:\/\/lens.org\/180-859-944-136-546","id":"2f2f4318-e186-4c9c-14ef-ae523531f6da","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Fxr (Nr1H4 ) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/180-859-944-136-546","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T21:43:21Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2008-01-15T00:00:00Z","subj_id":"https:\/\/lens.org\/193-102-672-633-342","id":"4ec8f2ed-f446-484e-a3f5-7bf8cc831174","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Farnesoid X Receptor Agonists","pid":"https:\/\/lens.org\/193-102-672-633-342","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T01:11:11Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-01-16T00:00:00Z","subj_id":"https:\/\/lens.org\/197-860-222-955-481","id":"0fef4b2b-fcfe-eb99-31cb-287fa0ccde60","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Fxr (Nr1H4) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/197-860-222-955-481","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T02:32:25Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-11-17T00:00:00Z","subj_id":"https:\/\/lens.org\/030-319-266-055-758","id":"09d22ade-d39f-82f9-3a30-86544a581bbd","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Reduction Of Hair Growth","pid":"https:\/\/lens.org\/030-319-266-055-758","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T05:50:38Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2003-02-26T00:00:00Z","subj_id":"https:\/\/lens.org\/036-172-447-350-398","id":"f0a67ec7-3f12-bc3e-9e82-91923fa57509","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Nr1H4 Nuclear Receptor Binding Compounds","pid":"https:\/\/lens.org\/036-172-447-350-398","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T07:20:25Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2003-10-28T00:00:00Z","subj_id":"https:\/\/lens.org\/038-587-900-763-631","id":"0c69948e-b038-2b6d-0132-84d6a70a6660","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Assays For Ligands For Nuclear Receptors","pid":"https:\/\/lens.org\/038-587-900-763-631","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T07:57:58Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-02-24T00:00:00Z","subj_id":"https:\/\/lens.org\/004-348-770-897-487","id":"bc28ad91-5c4c-7d4f-2f31-7d7df5b9c90a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Fxr (Nr1H4) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/004-348-770-897-487","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T09:14:22Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2006-01-17T00:00:00Z","subj_id":"https:\/\/lens.org\/004-919-656-844-038","id":"a5772e12-ca4d-a5dc-9ea4-c10d3eeb2638","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Compositions And Methods For Hepatoprotection And Treatment Of Cholestasis","pid":"https:\/\/lens.org\/004-919-656-844-038","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:42:14Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-06-28T00:00:00Z","subj_id":"https:\/\/lens.org\/049-752-301-917-569","id":"01ab0281-1101-f6a5-a623-eed31f54d39e","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Compositions And Methods For Modulating Fxr","pid":"https:\/\/lens.org\/049-752-301-917-569","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:51:05Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-02-10T00:00:00Z","subj_id":"https:\/\/lens.org\/057-491-099-109-53X","id":"6b828fa9-5d0b-ae25-d8bc-83470dbc7713","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Fxr (Nr1H4) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/057-491-099-109-53X","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T12:53:45Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-06-24T00:00:00Z","subj_id":"https:\/\/lens.org\/059-543-893-031-017","id":"ee228c77-2b99-a122-b4b7-de637b7e9835","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Treatment Of Diarrhoea","pid":"https:\/\/lens.org\/059-543-893-031-017","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T13:24:41Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-06-22T00:00:00Z","subj_id":"https:\/\/lens.org\/006-595-497-191-58X","id":"b24d27f9-e95e-f087-4773-75a6a3d4431a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Hydroxy Containing Fxr (Nr1H4) Modulating Compounds","pid":"https:\/\/lens.org\/006-595-497-191-58X","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T15:03:57Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-03-02T00:00:00Z","subj_id":"https:\/\/lens.org\/068-887-275-490-043","id":"c3fea39d-f64f-ae66-95e1-174f084242e7","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Fxr (Nr1H4) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/068-887-275-490-043","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T15:49:42Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-11-03T00:00:00Z","subj_id":"https:\/\/lens.org\/073-082-806-787-00X","id":"f4fd7de5-5126-81e6-153c-ec6b37399450","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Fused Tricyclic Pyrazole Derivatives Useful For Modulating Farnesoid X Receptors","pid":"https:\/\/lens.org\/073-082-806-787-00X","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T16:57:33Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2005-10-20T00:00:00Z","subj_id":"https:\/\/lens.org\/082-422-229-060-699","id":"3afdb636-1be1-a568-ddaf-c1f91d9993bd","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Agent For Controlling Cholesterol Homeostasis-Associated Gene Transcription Activity Mediated By Fxr Activation","pid":"https:\/\/lens.org\/082-422-229-060-699","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T19:36:37Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-09-22T00:00:00Z","subj_id":"https:\/\/lens.org\/085-765-849-367-61X","id":"5e17bdc1-3dee-cfe8-b021-4f22182144d4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Fxr (Nr1H4) Binding And Activity Modulating Compounds","pid":"https:\/\/lens.org\/085-765-849-367-61X","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T20:32:52Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-11-01T00:00:00Z","subj_id":"https:\/\/lens.org\/088-158-461-269-743","id":"d439c230-3dd7-ad87-92d7-b9a00e928e5b","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Amide Compound And Pharmaceutical Application Therefor","pid":"https:\/\/lens.org\/088-158-461-269-743","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T21:13:20Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2002-11-28T00:00:00Z","subj_id":"https:\/\/lens.org\/092-726-632-697-126","id":"3bdef1a2-283d-ebb5-a60e-eb0ded1bdb3a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Identification Of New Therapeutic Targets For Modulating Bile Acid Synthesis","pid":"https:\/\/lens.org\/092-726-632-697-126","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:31:17Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-12-09T00:00:00Z","subj_id":"https:\/\/lens.org\/093-984-161-805-394","id":"94ef22af-29fe-cf4d-ce5d-c1b91bae99e3","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Compositions And Methods For Treatment Of Fibrosis","pid":"https:\/\/lens.org\/093-984-161-805-394","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:53:00Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2008-05-02T00:00:00Z","subj_id":"https:\/\/lens.org\/009-640-794-728-282","id":"509fb0ca-49cc-44df-c159-fd3697c61026","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Farnesoid X Receptor Agonists","pid":"https:\/\/lens.org\/009-640-794-728-282","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T23:35:53Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2004-03-18T00:00:00Z","subj_id":"https:\/\/lens.org\/097-378-002-113-396","id":"4f459fbb-2d8c-e019-23da-fda5f21acc66","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Use Of A Farnesoid X Receptor Antagonist For Treating Hyperlipidemia","pid":"https:\/\/lens.org\/097-378-002-113-396","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T23:52:49Z","relation_type_id":"cites"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2019-06-25T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1080\/15384101.2019.1634955","id":"51df1139-328d-4692-8ae9-57a75e8378dd","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-06-26T21:20:57Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2019-07-02T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1038\/s41467-019-10853-2","id":"79bbb770-f0c3-4f89-b684-e2421d0cf55f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-07-03T13:21:23Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2012-10-31T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1371\/journal.pone.0048461","id":"c288445a-5922-4ce9-b101-57db452a2bd9","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-07-16T02:33:01Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2013-03-06T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1007\/s11095-013-1006-7","id":"1a4141d8-da9a-413f-8e8a-98fbed2b300f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-07-29T10:21:15Z","relation_type_id":"references"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"28276d12-b320-41ba-9272-bb0adc3466ff","occurred_at":"2019-08-01T14:29:33.000Z","subj_id":"https:\/\/doi.org\/10.7270\/q2hq40m3","id":"1cb67d39-b405-4385-8b8d-6d57ab9f621a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","subj":{"pid":"https:\/\/doi.org\/10.7270\/q2hq40m3","work_type_id":"Dataset"},"message_action":"create","source_id":"datacite","obj":{"pid":"https:\/\/doi.org\/10.1021\/jm0002127","work_type_id":"ScholarlyArticle"},"timestamp":"2019-08-01T16:39:42Z","relation_type_id":"is_derived_from"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2019-08-12T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1007\/s00018-019-03247-6","id":"3660c719-d2f9-4ec1-be14-44c8fdaf4c76","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-11-28T03:03:41Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2014-04-01T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1002\/hep.26714","id":"c5cfa67b-9c47-4052-8039-130c604b8e65","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-12-08T23:13:10Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1021\/jm0002127","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2012-11-01T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1089\/jir.2012.0008","id":"98aeac49-75dc-4ae1-b059-c8aa794e7390","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-12-21T12:59:21Z","relation_type_id":"references"}]}}